www.tickerreport.com ·
iqvia q1 earnings call highlights
Topic context
This topic has been covered 340774 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedIQVIA's earnings reflect strong demand for clinical research and commercial solutions, with AI integration improving efficiency. The record backlog indicates sustained revenue visibility. Impact is company-specific and sector-wide for healthcare services and AI in life sciences. No direct commodity or supply chain scarcity.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- IQVIA Q1 2026 revenue $4.151B, +8.4% YoY
- Adjusted EPS $2.90, +7.4% YoY
- R&D Solutions net new bookings $2.5B, backlog $34.2B record
- 192 AI agents deployed across workflows
- Full-year revenue guidance reaffirmed $17.15B-$17.35B, EPS raised to $12.65-$12.95
Mid-term margin expansion for clinical trial services and R&D solutions is expected to be around 2% over 1-4 weeks as AI integration improves efficiency.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- GLOBAL_HEALTHCAREmid
- GLOBAL_HEALTHCAREshort
Related stories
finance.yahoo.com
zillow zg q1 2026 earnings 225404880
finance.yahoo.com
nve nvec q4 2026 earnings 221728418
finance.yahoo.com
atkore atkr q4 2025 earnings 170127817
pharmiweb.com
celanese corporation reports first quarter earnings
tickerreport.com